LKB1 Deficiency Renders NSCLC Cells Sensitive to ERK Inhibitors-Reference-Cited by-同舟云学术

LKB1 Deficiency Renders NSCLC Cells Sensitive to ERK Inhibitors

Published:2020-03 Issue:3 Volume:15 Page:360-370
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Caiola Elisa,Iezzi Alice,Tomanelli Michele,Bonaldi Elisa,Scagliotti Arianna,Colombo Marika,Guffanti Federica,Micotti Edoardo,Garassino Marina Chiara,Minoli Lucia,Scanziani Eugenio,Broggini Massimo,Marabese Mirko

Funder

Associazione Italiana per la Ricerca sul Cancro

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference36 articles.

1. Unravelling the connection between metabolism and tumorigenesis through studies of the liver kinase B1 tumour suppressor;Shackelford;J Carcinog,2013

2. Prevalence and specificity of LKB1 genetic alterations in lung cancers;Matsumoto;Oncogene,2007

3. The LKB1-AMPK pathway: metabolism and growth control in tumour suppression;Shackelford;Nat Rev Cancer,2009

4. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress;Shaw;Proc Natl Acad Sci U S A,2004

5. LKB1: cancer, polarity, metabolism, and now fertility;Shaw;Biochem J,2008

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Caloric restriction and metformin selectively improved LKB1-mutated NSCLC tumor response to chemo- and chemo-immunotherapy;Journal of Experimental & Clinical Cancer Research;2024-01-02

2. The necroptosis signature and molecular mechanism of lung squamous cell carcinoma;Aging;2023-11-15

3. Modern therapies of nonsmall cell lung cancer;Journal of Applied Genetics;2023-09-12

4. Identification of an antigen-presenting cells/T/NK cells-related gene signature to predict prognosis and CTSL to predict immunotherapeutic response for lung adenocarcinoma: an integrated analysis of bulk and single-cell RNA sequencing;Cancer Immunology, Immunotherapy;2023-07-17

5. Glucocorticoid mediated inhibition of LKB1 mutant non-small cell lung cancers;Frontiers in Oncology;2023-03-23